💊 Can #GLP-1 agents prevent #cancer?

The signal from retrospective data is “probably as strong as it will ever be” but “now is the time” to validate findings prospectively, @theglpman @UTHealthSA says.

Read the latest in this #HealioExclusive 👇 vist.ly/5iygt

🩸Higher blood levels of two #ForeverChemicals may raise risk for aggressive #BreastCancer.

The associations are “quite strong”, Dr. Alexandra White @NIH says.

Data show relative risk increases of 67%-93%, though risks on “absolute scale” will be lower. vist.ly/5rqjw

🚩 “A landmark, practice changing trial.”

@ILSONDavis @MSKCancerCenter details why zanidatamab-hrii @JazzPharma ➕ chemotherapy with/without tislelizumab-jsgr #BeOne should be the new standard of care for #GastroesophagealAdenocarcinoma. #ESMO26. vist.ly/5rpjr

Treatment for platinum sensitive #OvarianCancer has not changed in years.

📊 Phase 1 trial data presented at @myESMO #ESMO26 showed nearly 8️⃣0️⃣% of women who took sofetabart mipitecan @EliLillyandCo plus bevacizumab achieved a response. vist.ly/5rjw6

🚨 Less than 25% of U.S. counties have #BladderCancer clinical trials.

🚨🚨 Only 3% of counties with the highest mortality have clinical trials.

🗨️ “Trial availability does not consistently reflect where disease burden is greatest,” @kor_shah @cityofhope vist.ly/5rjsc

💡 Adaira Landry, MD, MEd, shared tips for venturing into lay press writing in a Healio Community webinar.

Read about:
✅Finding a focus
✅Developing a story arc
✅Networking with writers
✅Amplifying the piece vist.ly/5rjmd

People frequently use botanical products like #kratom and #cannabis that are not regulated by #FDA.

@AmerMedicalAssn sent a letter to the FDA urging change.

🎙️ “They don’t think of [these products] as drugs." @DocAnitaGupta @HopkinsMedicine

🔗 bit.ly/4ej2x4o

👀 The public maintains a high level of trust in physicians for #cancer information.

However, trust has fallen significantly since the #pandemic in healthcare agencies.

🗨️ “People are more reticent to trust information,” @ToddBurus @universityofky vist.ly/5ri6s

📉 #BariatricSurgery linked to lower long-term risk for #obesity-related cancers.

Consistent benefits between men & women, and across age groups, support “equitable access” to surgery if indicated, per Dr. Cecilia Radkiewicz of Karolinska Institutet.
vist.ly/5rejm

🛏️ Between 30%-60% of women with #cancer have #insomnia.

Randomized trial data presented at @myESMO #ESMO26 showed more than 60% of women who completed a 6-week intervention with @Sleepio no longer had insomnia at 24 weeks. vist.ly/5rebx

❗Patients w/ EGFR-mutant non-small cell #LungCancer w/ MET overexpression/amplification who progress derive significant survival benefits from osimertinib ➕ savolitinib.

📊 Phase 3 trial data presented at @myESMO #ESMO26 showed a 45% improvement in PFS. vist.ly/5rdz2

🗨️ “Truly remarkable.”

Dr. Geoffrey Y. Ku @MSKCancerCenter on phase 3 trial data showing “unprecedented” survival benefit of zanidatamab-hrii @JazzPharma regimens for locally advanced/metastatic HER2+ #GastroesophagealAdenocarcinoma.

#ESMO26 vist.ly/5rcun

🌿 The @AmerMedicalAssn recently wrote a letter to the #FDA imploring more regulation of botanical products from #kratom & other substances.

🗨️ “Calling something ‘natural’ doesn’t make it safe. We need science, not social media hype,” @PresAmerMed vist.ly/5r9az

❓ Are ambient #AI scribes impactful in oncology?

📖 Data from @ASCO #ASCOQLTY26 detailing one center’s usage showed slight improvement in after-hours work, significantly less excessive note writing & that most clinicians would recommend it to others. vist.ly/5r97j

❗The latest @ASTCT Update blog is live

Dr. Sergio A. Giralt @MSKCancerCenter explains why multidisciplinary collaboration to prevent & manage #transplantation & #CellularTherapy toxicity is essential & previews a conference dedicated to the topic. vist.ly/5r8x5

🫁 Adding #tarlatamab @Amgen to #durvalumab @AstraZeneca for first-line maintenance of extensive-stage small cell #LungCancer improves OS, PFS, per #ESMO26 data.

📊 The efficacy is “unprecedented” in this setting, @sands_jacob @DanaFarber tells @GoHealio. vist.ly/5r7ht

Coffee break + CME? ☕📚 Yes please!

Healio makes it possible: bit.ly/47D8Rj7

🔥Extended endocrine therapy can cause adverse effects for women with #BreastCancer, such as muscle pain and hot flashes.

📖Data from @JAMANetworkOpen show Breast Cancer Index helps physicians and patients feel more confident in treatment recommendations. vist.ly/5r432

📊 Randomized phase 3 trial data show sacituzumab tirumotecan @Merck improved survival 7️⃣ months vs. chemotherapy for advanced or recurrent #EndometrialCancer.

🗨️ Dr. Domenica Lorusso, Humanitas San Pio X, called it a “new standard of care” at #ESMO26. vist.ly/5r3u4

Identifying prognostic factors in #cardiooncology is an urgent need. New findings highlight how adhering to heart-healthy diets enhances overall survival and quality of life for cancer survivors by reducing CVD risks. 🩺🍏 #OncoAlert #MINDdiet

vist.ly/5qvrd

New data from #TCT2026 highlights a critical healthcare disparity: Patients with cancer who experience an #AcuteMI are often underdiagnosed and undertreated.

Read more 👇
vist.ly/5q24g

#CardioOncology @HemOncToday @TCTConference